These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25526474)

  • 1. Genomic profiling of patient-derived colon cancer xenograft models.
    Lee WS; Kim HY; Seok JY; Jang HH; Park YH; Kim SY; Shin DB; Hong S
    Medicine (Baltimore); 2014 Dec; 93(28):e298. PubMed ID: 25526474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer patient-derived xenografted tumors maintain characteristic features of the original tumors.
    Cho YB; Hong HK; Choi YL; Oh E; Joo KM; Jin J; Nam DH; Ko YH; Lee WY
    J Surg Res; 2014 Apr; 187(2):502-9. PubMed ID: 24332554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and preclinical application of a patient-derived xenograft model for uterine cancer.
    Jeong SY; Cho YJ; Ryu JY; Choi JJ; Hwang JR; Kim B; Lee YY; Kim HS; Lee JW
    Gynecol Oncol; 2021 Jul; 162(1):173-181. PubMed ID: 33972086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and characterization of a colon PDX model that reproduces drug responsiveness and the mutation profiles of its original tumor.
    Seol HS; Kang HJ; Lee SI; Kim NE; Kim TI; Chun SM; Kim TW; Yu CS; Suh YA; Singh SR; Chang S; Jang SJ
    Cancer Lett; 2014 Apr; 345(1):56-64. PubMed ID: 24333725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A large collection of integrated genomically characterized patient-derived xenografts highlighting the heterogeneity of triple-negative breast cancer.
    Coussy F; de Koning L; Lavigne M; Bernard V; Ouine B; Boulai A; El Botty R; Dahmani A; Montaudon E; Assayag F; Morisset L; Huguet L; Sourd L; Painsec P; Callens C; Chateau-Joubert S; Servely JL; Larcher T; Reyes C; Girard E; Pierron G; Laurent C; Vacher S; Baulande S; Melaabi S; Vincent-Salomon A; Gentien D; Dieras V; Bieche I; Marangoni E
    Int J Cancer; 2019 Oct; 145(7):1902-1912. PubMed ID: 30859564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TP53, PIK3CA, FBXW7 and KRAS Mutations in Esophageal Cancer Identified by Targeted Sequencing.
    Zheng H; Wang Y; Tang C; Jones L; Ye H; Zhang G; Cao W; Li J; Liu L; Liu Z; Zhang C; Lou F; Liu Z; Li Y; Shi Z; Zhang J; Zhang D; Sun H; Dong H; Dong Z; Guo B; Yan HE; Lu Q; Huang X; Chen SY
    Cancer Genomics Proteomics; 2016; 13(3):231-8. PubMed ID: 27107065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A personalized preclinical model to evaluate the metastatic potential of patient-derived colon cancer initiating cells.
    Puig I; Chicote I; Tenbaum SP; Arqués O; Herance JR; Gispert JD; Jimenez J; Landolfi S; Caci K; Allende H; Mendizabal L; Moreno D; Charco R; Espín E; Prat A; Elez ME; Argilés G; Vivancos A; Tabernero J; Rojas S; Palmer HG
    Clin Cancer Res; 2013 Dec; 19(24):6787-801. PubMed ID: 24170545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and genomic characterizations of patient-derived esophageal squamous cell carcinoma xenograft models using biopsies for treatment optimization.
    Zou J; Liu Y; Wang J; Liu Z; Lu Z; Chen Z; Li Z; Dong B; Huang W; Li Y; Gao J; Shen L
    J Transl Med; 2018 Jan; 16(1):15. PubMed ID: 29370817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and Characterisation by Expression Microarray of Patient-Derived Xenograft Panel of Human Pancreatic Adenocarcinoma Patients.
    Roche S; O'Neill F; Murphy J; Swan N; Meiller J; Conlon NT; Geoghegan J; Conlon K; McDermott R; Rahman R; Toomey S; Straubinger NL; Straubinger RM; O'Connor R; McVey G; Moriarty M; Clynes M
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32024004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment and characterization of melanoma patient-derived xenograft models for preclinical evaluation of novel therapeutics.
    Yan J; Wu X; Yu J; Ma M; Yu H; Xu T; Tang H; Xu L; Dai J; Si L; Chi Z; Sheng X; Cui C; Guo J; Kong Y
    Melanoma Res; 2018 Dec; 28(6):527-535. PubMed ID: 30086074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and genetically characterization of patient-derived xenograft models of cervical cancer.
    Zou S; Ye M; Zhang JA; Ji H; Chen Y; Zhu X
    BMC Med Genomics; 2022 Sep; 15(1):191. PubMed ID: 36076209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Establishment and its biological characteristics of patient-derived lung cancer xenograft models].
    Zhuo Y; Wu Y; Guo A; Chen S; Su J
    Zhongguo Fei Ai Za Zhi; 2010 Jun; 13(6):568-74. PubMed ID: 20681441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An original patient-derived xenograft of prostate cancer with cyst formation.
    Yoshikawa T; Kobori G; Goto T; Akamatsu S; Terada N; Kobayashi T; Tanaka Y; Jung G; Kamba T; Ogawa O; Inoue T
    Prostate; 2016 Aug; 76(11):994-1003. PubMed ID: 27098584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies.
    Jäger W; Xue H; Hayashi T; Janssen C; Awrey S; Wyatt AW; Anderson S; Moskalev I; Haegert A; Alshalalfa M; Erho N; Davicioni E; Fazli L; Li E; Collins C; Wang Y; Black PC
    Oncotarget; 2015 Aug; 6(25):21522-32. PubMed ID: 26041878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inter- and intra-tumor profiling of multi-regional colon cancer and metastasis.
    Kogita A; Yoshioka Y; Sakai K; Togashi Y; Sogabe S; Nakai T; Okuno K; Nishio K
    Biochem Biophys Res Commun; 2015 Feb; 458(1):52-6. PubMed ID: 25623536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors.
    Wang D; Pham NA; Tong J; Sakashita S; Allo G; Kim L; Yanagawa N; Raghavan V; Wei Y; To C; Trinh QM; Starmans MH; Chan-Seng-Yue MA; Chadwick D; Li L; Zhu CQ; Liu N; Li M; Lee S; Ignatchenko V; Strumpf D; Taylor P; Moghal N; Liu G; Boutros PC; Kislinger T; Pintilie M; Jurisica I; Shepherd FA; McPherson JD; Muthuswamy L; Moran MF; Tsao MS
    Int J Cancer; 2017 Feb; 140(3):662-673. PubMed ID: 27750381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and characterization of uterine sarcoma and carcinosarcoma patient-derived xenograft models.
    Cuppens T; Depreeuw J; Annibali D; Thomas D; Hermans E; Gommé E; Trinh XB; Debruyne D; Moerman P; Lambrechts D; Amant F
    Gynecol Oncol; 2017 Sep; 146(3):538-545. PubMed ID: 28625393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next-Generation Sequencing of Matched Primary and Metastatic Rectal Adenocarcinomas Demonstrates Minimal Mutation Gain and Concordance to Colonic Adenocarcinomas.
    Crumley SM; Pepper KL; Phan AT; Olsen RJ; Schwartz MR; Portier BP
    Arch Pathol Lab Med; 2016 Jun; 140(6):529-35. PubMed ID: 26536055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic profiling is predictive of response to cisplatin treatment but not to PI3K inhibition in bladder cancer patient-derived xenografts.
    Wei L; Chintala S; Ciamporcero E; Ramakrishnan S; Elbanna M; Wang J; Hu Q; Glenn ST; Murakami M; Liu L; Gomez EC; Sun Y; Conroy J; Miles KM; Malathi K; Ramaiah S; Anbarasu A; Woloszynska-Read A; Johnson CS; Conroy J; Liu S; Morrison CD; Pili R
    Oncotarget; 2016 Nov; 7(47):76374-76389. PubMed ID: 27823983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of the expression of cancer stem cell-related markers CD133 and CD44 in hepatocellular carcinoma: From patients to patient-derived tumor xenograft models.
    Zhao Q; Zhou H; Liu Q; Cao Y; Wang G; Hu A; Ruan L; Wang S; Bo Q; Chen W; Hu C; Xu D; Tao F; Cao J; Ge Y; Yu Z; Li L; Wang H
    Oncotarget; 2016 Jul; 7(30):47431-47443. PubMed ID: 27329727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.